Kenvue Inc. (NYSE:KVUE) Given Average Recommendation of "Hold" by Brokerages

Kenvue Inc. (NYSE:KVUE - Get Free Report) has been given an average rating of "Hold" by the twelve analysts that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $22.64.

Several research firms have commented on KVUE. Citigroup lowered their price target on shares of Kenvue from $21.00 to $20.00 and set a "neutral" rating for the company in a report on Wednesday, July 10th. Royal Bank of Canada cut Kenvue from an "outperform" rating to a "sector perform" rating and set a $24.00 price objective for the company. in a research report on Tuesday, September 24th. Deutsche Bank Aktiengesellschaft boosted their target price on Kenvue from $23.00 to $24.00 and gave the stock a "buy" rating in a research report on Wednesday, August 7th. Piper Sandler increased their price objective on Kenvue from $20.00 to $21.00 and gave the company a "neutral" rating in a research note on Monday, September 23rd. Finally, UBS Group increased their target price on Kenvue from $20.00 to $22.00 and gave the stock a "neutral" rating in a research report on Wednesday, August 7th.

Institutional Investors Weigh In On Kenvue

A number of institutional investors have recently modified their holdings of KVUE. BI Asset Management Fondsmaeglerselskab A S bought a new stake in Kenvue in the first quarter worth approximately $1,050,000. Lorne Steinberg Wealth Management Inc. lifted its stake in Kenvue by 59.0% during the second quarter. Lorne Steinberg Wealth Management Inc. now owns 154,690 shares of the company's stock worth $2,812,000 after purchasing an additional 57,375 shares during the period. Kennon Green & Company LLC lifted its holdings in Kenvue by 140.7% during the 2nd quarter. Kennon Green & Company LLC now owns 159,106 shares of the company's stock valued at $2,893,000 after purchasing an additional 93,008 shares during the last quarter. Czech National Bank raised its stake in shares of Kenvue by 20.3% in the second quarter. Czech National Bank now owns 364,886 shares of the company's stock worth $6,634,000 after acquiring an additional 61,635 shares during the last quarter. Finally, Crestwood Advisors Group LLC raised its holdings in Kenvue by 14.8% during the 2nd quarter. Crestwood Advisors Group LLC now owns 1,537,348 shares of the company's stock worth $27,950,000 after purchasing an additional 198,607 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Kenvue Stock Performance

KVUE traded up $0.19 during trading on Tuesday, reaching $23.23. 17,779,775 shares of the company's stock were exchanged, compared to its average volume of 18,105,982. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.99 and a quick ratio of 0.68. The company's fifty day simple moving average is $22.57 and its 200-day simple moving average is $20.47. Kenvue has a 1 year low of $17.67 and a 1 year high of $23.57. The stock has a market capitalization of $44.48 billion, a P/E ratio of 40.04, a price-to-earnings-growth ratio of 2.97 and a beta of 1.36.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.28 by $0.04. The firm had revenue of $4 billion during the quarter, compared to analysts' expectations of $3.93 billion. Kenvue had a return on equity of 21.80% and a net margin of 7.23%. The firm's revenue for the quarter was down .3% on a year-over-year basis. During the same period in the previous year, the business earned $0.32 earnings per share. As a group, research analysts predict that Kenvue will post 1.08 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, November 27th. Investors of record on Wednesday, November 13th will be given a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a yield of 3.53%. The ex-dividend date of this dividend is Wednesday, November 13th. Kenvue's payout ratio is 141.38%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.